ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,520Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 973

$517K Total Retail Price of All Prescriptions

Rank: 137 out of 973

357 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
23% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 357 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

18% of this provider’s 357 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 9,302 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 549 499 1 1
LISINOPRIL 449 392 2 3
LEVOTHYROXINE SODIUM 431 390 3 2
HYDROCODONE-ACETAMINOPHEN 426 330 S3 4 4
POTASSIUM CHLORIDE 414 386 5 9
AMLODIPINE BESYLATE 372 351 6 7
ATENOLOL 290 286 7 16
WARFARIN SODIUM 278 263 8 10
HYDROCHLOROTHIAZIDE 270 226 9 11
FUROSEMIDE 262 238 10 6
METOPROLOL TARTRATE 261 243 11 13
OMEPRAZOLE 205 162 12 5
ALENDRONATE SODIUM 199 191 13 24
TRIAMTERENE-HCTZ 174 171 14 51
ATORVASTATIN CALCIUM 164 162 15 15
PRAVASTATIN SODIUM 151 130 16 22
GABAPENTIN 143 114 17 12
SERTRALINE HCL 135 131 18 21
SPIRONOLACTONE 117 117 19 49
LOSARTAN POTASSIUM 110 109 20 19
METFORMIN HCL 108 82 21 8
CYMBALTA 106 63 22 40
MIRTAZAPINE 98 77 23 43
CITALOPRAM HBR 97 92 24 14
TRAMADOL HCL 95 95 25 18
AZITHROMYCIN 94 84 26 47
ZOLPIDEM TARTRATE 94 93 26 20
LANTUS 91 74 28 39
PREDNISONE 90 84 29 33
HUMALOG 83 68 30 127
MELOXICAM 80 78 31 23
ALLOPURINOL 78 78 32 29
CIPROFLOXACIN HCL 72 71 33 57
KLOR-CON 10 67 55 34 128
OXYCODONE-ACETAMINOPHEN 67 52 S2 34 89
METFORMIN HCL ER 67 62 34 58
FENTANYL 59 51 S2 37 53
NEXIUM 59 46 37 30
TRAZODONE HCL 55 44 39 48
TAMSULOSIN HCL 55 54 39 28
VESICARE 54 53 41 133
ADVAIR DISKUS 52 43 42 60
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.